BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 239 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,421 | +21.7% | 230 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $1,168 | -15.2% | 230 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,378 | -15.4% | 230 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,628 | -34.9% | 230 | -35.2% | 0.00% | -50.0% |
| Q2 2023 | $2,499 | +30.3% | 355 | +54.3% | 0.00% | 0.0% |
| Q1 2023 | $1,918 | +63833.3% | 230 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $3 | -99.9% | 230 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | +50.0% | 230 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $2,000 | -50.0% | 230 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,000 | +33.3% | 230 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $3,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |